Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension

被引：0

作者：

Deodhar, Atul ^{[1
]}

van der Heijde, Desiree ^{[2
]}

Sieper, Joachim ^{[3
]}

Van den Bosch, Filip ^{[4
]}

Maksymowych, Walter ^{[5
]}

Kim, Tae-Hwan ^{[6
]}

Kishimoto, Mitsumasa ^{[7
]}

Ostor, Andrew ^{[8
]}

Combe, Bernard ^{[9
]}

Sui, Yunxia ^{[10
]}

Wang, Xin ^{[10
]}

Chu, Alvina D. ^{[10
]}

Song, In-Ho ^{[10
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Ghent Univ Hosp, Ghent, Belgium

[5] Univ Alberta, Edmonton, AB, Canada

[6] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea

[7] Kyorin Univ, Dept Nephrol & Rheumatol, Sch Med, Tokyo, Japan

[8] Monash Univ, Cabrini Med Ctr, Malvern, Vic, Australia

[9] Univ Montpellier, Montpellier, France

[10] AbbVie Inc, N Chicago, IL USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2023

引用

页数：4

共 50 条

[41] Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension
Denys Fontaine
Yves Lazorthes
Patrick Mertens
Serge Blond
Gilles Géraud
Nelly Fabre
Malou Navez
Christian Lucas
Francois Dubois
Sebastien Gonfrier
Philippe Paquis
Michel Lantéri-Minet
The Journal of Headache and Pain, 2010, 11 : 23 - 31
[42] A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study with an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis (RG)
Zuraw, Qing
Cui, Xiaoming
Fang, Jianmin
ANNALS OF NEUROLOGY, 2024, 96 : S86 - S87
[43] Safety and efficacy of combination therapy of iguratimod with methotrexate for patients with active rheumatoid arthritis with an inadequate response to methotrexate: An open-label extension of a randomized, double-blind, placebo-controlled trial
Hara, Masako
Ishiguro, Naoki
Katayama, Kou
Kondo, Masakazu
Sumida, Takayuki
Mimori, Tsuneyo
Soen, Satoshi
Nagai, Kota
Yamaguchi, Tomonobu
Yamamoto, Kazuhiko
MODERN RHEUMATOLOGY, 2014, 24 (03) : 410 - 418
[44] Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
Aman, Michael G.
Findling, Robert L.
Hardan, Antonio Y.
Hendren, Robert L.
Melmed, Raun D.
Kehinde-Nelson, Ola
Hsu, Hai-An
Trugman, Joel M.
Palmer, Robert H.
Graham, Stephen M.
Gage, Allyson T.
Perhach, James L.
Katz, Ephraim
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (05) : 403 - 412
[45] Switching from double-blind entacapone or placebo to open-label opicapone: NMSS results of the 1-year extension BIPARK-I study
Fabregues, O.
Tolosa, E.
Ferreira, J.
Lees, A.
Santos, A.
Arbe, E.
Rocha, J-F.
Soares-da-Silva, P.
MOVEMENT DISORDERS, 2018, 33 : S142 - S142
[46] SWITCHING FROM DOUBLE-BLIND ENTACAPONE OR PLACEBO TO OPEN-LABEL OPICAPONE: NMSS RESULTS (1-YEAR EXTENSION BIPARK-I STUDY)
Fabregues, O.
Tolosa, E.
Ferreira, J.
Lees, A.
Santos, A.
Rocha, J.
Soares-Da-Silva, P.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E49 - E49
[47] Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
Boonen, Steven
Lorenc, Roman S.
Wenderoth, Dietrich
Stoner, Karen J.
Eusebio, Rachelle
Orwoll, Eric S.
BONE, 2012, 51 (03) : 383 - 388
[48] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
Mazurov, V.
Korolev, M.
Pristrom, A.
Kundzer, A.
Soroka, N.
Kastanayan, A.
Povarova, T.
Plaksina, T.
Antipova, O.
Kretchikova, D.
Smakotina, S.
Tciupa, O.
Puntus, E.
Raskina, T.
Shilova, L.
Kropotina, T.
Nesmeyanova, O.
Popova, T.
Vinogradova, I.
Linkova, I.
Plotnikova, A.
Pukhtinskaia, P.
Zinkina-Orikhan, A.
Eremeeva, A.
Lutckii, A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 596 - 596
[49] The efficacy and safety of abatacept or infliximab in ra patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial
Bessette, Louis
Schiff, Michael
Kieserman, Mauro
JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1627 - 1627
[50] Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.
Gorman, JD
Sack, KE
Davis, JC
ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403

← 1 2 3 4 5 →